CRP and S&A for Inpatient Veterans
The purpose of this study is to evaluate how well three types of treatments work to improve the outcomes for people with substance use problems. Veterans admitted to the Charleston VA Psychiatric inpatient unit may be invited to participate. The three types of treatments that will be evaluated are: 1. Combined Recovery
| Condition(s) | Alcoholism, Substance-related Disorders, Dual Diagnosis |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The purpose of this study is to evaluate how well three types of treatments work to improve the outcomes for people with substance use problems. Veterans admitted to the Charleston VA Psychiatric inpatient unit may be invited to participate. The three types of treatments that will be evaluated are: 1. Combined Recovery Program (CRP), a six-session treatment group delivered on the inpatient unit. 2. A Home Telehealth program, called Stable and Able (S\&A), provided just prior to discharge and provides additional support for up to 3 months 3. Treatment-as-usual (TAU), which is the treatment currently provided on the unit, consisting of various mental health topics and sessions designed to help with recovery. Participation begins on the inpatient unit, beginning with CRP and/or TAU, and may c |
| Who can participate | Inclusion Criteria: * Meeting DSM-V criteria for current SUD diagnosis of alcohol and/or illicit drug use disorder * Use of substances in past 30 days prior to date of index inpatient admission * Able to comprehend English * Able to provide informed consent * Functioning at an intellectual level sufficient to allow accurate completion of all assessments * Willing to commit to 6 group inpatient therapy sessions, telehealth S\&A, as well as baseline, and 1-and 3-month follow-up assessments Exclusion Criteria: * Auditory or visual impairment that would interfere with study procedures * Inability to speak or understand English * Acutely psychotic patients |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | VA Office of Research and Development |
| Locations | Charleston, South Carolina, United States |
| Start date | 2022-09-06 |
| NCT ID | NCT05054738 |
| Official listing | https://clinicaltrials.gov/study/NCT05054738 |